Publication | Closed Access

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

Lymphoid NeoplasiaRadiation OncologyCancer ImmunosurveillanceMedicineT-regulatory CellImmunologyAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyOncologyCell TransplantationT Cell LymphomaCancer Research